Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Kooij Louise Frederika
Chief Accounting Officer at NewAmsterdam Pharma Co N.V. Filing since 1 Oct 2024.
CIK 0002004379
Company
Date
Role
Action
Shares
Amount
Of holding
NAMS
NewAmsterdam Pharma Co N.V.
20 Jul 2026
Chief Accounting Officer
Sold on a plan
105,000
$3.19M
81.2%
NAMS
NewAmsterdam Pharma Co N.V.
22 Jun 2026
Chief Accounting Officer
Sold on a plan
40,000
$1.21M
62.2%
NAMS
NewAmsterdam Pharma Co N.V.
26 May 2026
Chief Accounting Officer
Sold on a plan
65,000
$2.32M
72.7%
NAMS
NewAmsterdam Pharma Co N.V.
28 Jan 2026
Chief Accounting Officer
Sold on a plan
32,612
$1.04M
57.2%
NAMS
NewAmsterdam Pharma Co N.V.
27 Jan 2026
Chief Accounting Officer
Sold on a plan
39,816
$1.30M
62.0%
NAMS
NewAmsterdam Pharma Co N.V.
26 Jan 2026
Chief Accounting Officer
Sold on a plan
34,400
$1.13M
58.6%
NAMS
NewAmsterdam Pharma Co N.V.
23 Jan 2026
Chief Accounting Officer
Sold on a plan
38,172
$1.29M
61.1%
NAMS
NewAmsterdam Pharma Co N.V.
5 Jan 2026
Chief Accounting Officer
Sold on a plan
2,647
$88.01K
17.6%
NAMS
NewAmsterdam Pharma Co N.V.
26 Dec 2025
Chief Accounting Officer
Sold on a plan
43,872
$1.55M
74.5%
NAMS
NewAmsterdam Pharma Co N.V.
24 Dec 2025
Chief Accounting Officer
Sold on a plan
26,011
$928.07K
63.4%
NAMS
NewAmsterdam Pharma Co N.V.
23 Dec 2025
Chief Accounting Officer
Sold on a plan
75,117
$2.72M
83.4%
NAMS
NewAmsterdam Pharma Co N.V.
9 Sep 2025
Chief Accounting Officer
Sold at will
150,000
$3.87M
90.9%
NAMS
NewAmsterdam Pharma Co N.V.
3 Sep 2025
Chief Accounting Officer
Sold at will
18,073
$453.45K
54.6%
NAMS
NewAmsterdam Pharma Co N.V.
25 Aug 2025
Chief Accounting Officer
Sold at will
8,269
$205.57K
35.5%
NAMS
NewAmsterdam Pharma Co N.V.
4 Mar 2025
Chief Accounting Officer
Sold at will
150,000
$3.06M
90.9%
NAMS
NewAmsterdam Pharma Co N.V.
1 Oct 2024
Chief Accounting Officer
Sold at will
45,000
$707.40K
100%
16 decisions on file.
